Literature DB >> 569669

Idiopathic hypertrophic subaortic stenosis as observed in a large community hospital: relation to age and history of hypertension.

T J Petrin, M E Tavel.   

Abstract

The character of idiopathic hypertrophic subaortic stenosis (IHSS) was studied retrospectively in a large community hospital for the six-year period, 1968--1974. Cases were discovered by examining the records of the Cardiac Non-Invasive Laboratory (phono- and echocardiography). Of the 46 cases of IHSS identified, 39 were in patients of the 50--81 age group. Thirty-two (82 percent) of the 39 patients were women, and 25 (78 percent) of these had a significant degree of hypertension. The hypertension had been present for more than five years in 62 percent of the cases. In 84 percent of the elderly females, the cardiac murmur had been present for less than ten years, and in 65 percent for less than five years. There was no family history of IHSS. Eighteen of the 46 IHSS patients underwent cardiac catheterization which confirmed the accuracy of the cardiographic data in all cases. The results of this study indicated that IHSS is usually nonfamilial, predominates in elderly females, and tends to be acquired after a lengthy period of hypertension. Cardiographic data appear highly specific diagnostically, often rendering cardiac catheterization unnecessary. Previous studies have not clearly defined the role of hypertension in the development of IHSS, at least partly because of the highly selective nature of most series reported from referral centers. These series often contain large numbers of younger patients.

Entities:  

Mesh:

Year:  1979        PMID: 569669     DOI: 10.1111/j.1532-5415.1979.tb01720.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  4 in total

1.  Hypertrophic cardiomyopathy in the elderly.

Authors:  L M Shapiro
Journal:  Br Heart J       Date:  1990-05

2.  Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients.

Authors:  F H Gietzen; C J Leuner; L Obergassel; C Strunk-Mueller; H Kuhn
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

3.  Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study.

Authors:  Hope E Buell; Rodney H Stables; Elizabeth R DeLong; Kathy B Shuping; Donna M Killip; Harry M Lever; William J McKenna; David Rubin; Ulrich Sigwart; Morimasa Takayama; Galen S Wagner; Eric L Eisenstein; William H Spencer
Journal:  J Med Syst       Date:  2002-08       Impact factor: 4.460

4.  Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States.

Authors:  Michael Butzner; Ethan Rowin; Amin Yakubu; Josiah Seale; Laura A Robertson; Phil Sarocco; Martin S Maron
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.